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Precise control of mitochondrial DNA gene expres-
sion is critical for regulationof oxidativephosphoryla-
tion capacity in mammals. The MTERF protein family
plays a key role in this process, and itsmembers have
been implicated in regulation of transcription initia-
tion and site-specific transcription termination. We
now demonstrate that a member of this family,
MTERF4, directly controls mitochondrial ribosomal
biogenesis and translation.MTERF4 formsastoichio-
metric complex with the ribosomal RNAmethyltrans-
feraseNSUN4 and is necessary for recruitment of this
factor to the large ribosomal subunit. LossofMTERF4
leads to defective ribosomal assembly and a drastic
reduction in translation. Our results thus show that
MTERF4 is an important regulator of translation in
mammalian mitochondria.
INTRODUCTION
Impaired expression of mtDNA is a well-recognized cause of
humanmitochondrial disease (Larsson andClayton, 1995; Shou-
bridge, 2001; Smeitink et al., 2006; Zeviani and Di Donato, 2004)
and is also commonly observed in normal human aging
(Krishnan et al., 2007; Larsson, 2010). The machinery that regu-
lates expression of mammalian mtDNA inside the mitochondrial
network is only partly understood, despite its profound impor-
tance for regulation of oxidative phosphorylation in response to
physiological demand and disease states.
The basal mammalian mtDNA transcription machinery con-
sists of three proteins expressed in all cell types, i.e., mitochon-
drial RNA polymerase (POLRMT), mitochondrial transcriptionCfactor A (TFAM) (Parisi and Clayton, 1991), and mitochondrial
transcription factor B2 (TFB2M) (Bogenhagen, 1996; Falkenberg
et al., 2002; Litonin et al., 2010; Metodiev et al., 2009). POLRMT
forms a heterodimer with TFB2M (Falkenberg et al., 2002), and
whereas the polymerase is responsible for promoter recognition,
TFB2M contributes to the formation of the catalytic site by inter-
acting with both the priming substrate and the DNA template
(Gaspari et al., 2004; Sologub et al., 2009). POLRMT is structur-
ally related to bacteriophage T7 RNA polymerase (Shutt and
Gray, 2006a), whereas TFB2M is homologous to a class of highly
conserved bacterial dimethyladenosine methyltransferases that
modify the rRNA of the small ribosomal subunit (Shutt and Gray,
2006b). There is a closely related paralog of TFB2M in mamma-
lian cells, denoted TFB1M, and conditional knockout has re-
vealed that TFB1M has no major role in mtDNA transcription,
but it instead functions as a methyltransferase essential for mito-
chondrial translation (Metodiev et al., 2009).
TFAM is required for transcription initiation, and not even abor-
tive transcription occurs at mammalian mtDNA promoters in its
absence (Falkenberg et al., 2002; Gaspari et al., 2004). In addi-
tion, TFAM has biophysical properties consistent with a role in
packaging mtDNA into DNA-protein structures, denoted nucle-
oids (Gangelhoff et al., 2009; Kaufman et al., 2007). Genetic
manipulation of TFAM levels in mice directly influences mtDNA
levels in vivo (Ekstrand et al., 2004; Larsson et al., 1998), further
supporting a direct role for TFAM in mtDNA organization and
regulation of mtDNA copy number.
The mitochondrial transcription termination factor 1 (MTERF1)
was initially identified as a DNA-binding protein with a specific
binding site in the tRNAL1 gene, downstream of the genes
encoding 12S and 16S rRNA (Hess et al., 1991; Kruse et al.,
1989). MTERF1 has a strong transcription termination activity
in vitro (Asin-Cayuela et al., 2005; Hess et al., 1991) and has
also been described to interact with the heavy strand promoter
(HSP) (Martin et al., 2005). It has also been reported thatMTERF1ell Metabolism 13, 527–539, May 4, 2011 ª2011 Elsevier Inc. 527
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MTERF1 promotes replication stalling (Hyva¨rinen et al., 2007).
MTERF1 belongs to a large family of proteins localized to mito-
chondria in metazoans and plants (Linder et al., 2005). There
are four MTERF family members in vertebrates (MTERF1–4).
The atomic structures of MTERF1 (Yakubovskaya et al., 2010)
and MTERF3 (Spa˚hr et al., 2010) were recently solved, revealing
strong structural similarities (Gustafsson and Larsson, 2010).
MTERF4 is predicted to have a fold similar to MTERF1 and
MTERF3, with positively charged surface areas for nucleic acid
interaction (Spa˚hr et al., 2010).
Mice lacking MTERF2 are viable, but develop myopathy and
memory deficits concomitant with an imbalance inmitochondrial
transcript levels when being challenged by a ketogenic diet
(Wenz et al., 2009). MTERF3 has been shown to have an
essential role since germline homozygous knockouts die in
midgestation (Park et al., 2007). Its conditional inactivation in
the heart and in vitro transcription assays revealed an important
role of MTERF3 as a repressor of mtDNA transcription (Park
et al., 2007).
In this study, we report that MTERF4 surprisingly forms a
stoichiometric complex with the NSUN4 methyltransferase.
MTERF4 is required for targeting of the NSUN4 RNA methyl-
transferase to the mitochondrial ribosome. In the absence of
MTERF4, both subunits of the ribosome are present at increased
levels, but they do not interact to form a functional assembled
ribosome. Our results thus show that MTERF4 is an essential
regulator of translation in mammalian mitochondria.
RESULTS
MTERF4 Is a Mitochondrial Protein
Northern blot analyses showed a ubiquitous expression of
MTERF4 transcripts in the mouse (Figure S1A). We found
a high probability for mitochondrial localization of MTERF4 with
the Mitoprot (58.8%) and TargetP (75.7%) softwares. The
subcellular localization of MTERF4 fused at its C terminus to
enhanced green fluorescent protein (EGFP) was determined by
transfection of HeLa cells and subsequent live-cell imaging
with MitoTracker Deep Red FM counterstaining. The MTERF4-
EGFP colocalizes with the mitochondrial network with a colocal-
ization rate of 96.3% ± 2.8% (N = 8 analyzed cells) (Figure S1B).
Mitochondrial in vitro import of radiolabeled MTERF4 was
dependent on the mitochondrial membrane potential and was
associated with cleavage of the mitochondrial leader peptide,
as typically seen for mitochondrial matrix proteins (Figure S1C).
We proceeded to determine the amino-terminal sequence of the
mitochondrial isoform of MTERF4 purified from stably trans-
fected HeLa cells with plasmids encoding hMTERF4 with a car-
boxy-terminal Flag-tag (hMTERF4-Flag). Sequencing by Edman
degradation revealed two distinct N-terminal ends correspond-
ing to postimport processing distal to amino acids 42 and 47
of the precursor form (Figure S1D).
MTERF4 Is Essential for Embryonic Development
in the Mouse
We generated a conditional Mterf4 knockout allele by flanking
exon 2 with loxP sequences, and heterozygous Mterf4neo-loxP
mice were mated to Flp-deleter mice to excise the neomycin528 Cell Metabolism 13, 527–539, May 4, 2011 ª2011 Elsevier Inc.selection marker (Figures 1A and 1B). The resulting Mterf4+/loxP
mice were mated to mice ubiquitously expressing cre-recombi-
nase (+/b-actin-cre mice), and heterozygous Mterf4 knockout
mice were obtained (genotype Mterf4+/) (Figure 1C). We inter-
crossed Mterf4+/ mice but obtained no homozygous knockout
mice of the genotype Mterf4/ (n = 0 in 164 analyzed pups),
whereas the other genotypes, Mterf4+/ (n = 115) and Mterf4+/+
(n = 49), were obtained at the expected Mendelian ratios. These
results strongly indicate embryonic lethality, and we therefore
proceeded to PCR genotype staged embryos obtained from
Mterf4+/ intercrosses (Figures 1D–1F). At embryonic day 8.5
(E8.5, n = 40 analyzed embryos), we found that a significant
proportion of the embryos (n = 10; 25%) had a profoundlymutant
phenotype with much reduced size, lack of heart, and no optic
discs (Figure 1D). The mutant embryos all had the genotype
Mterf4/ (Figures 1E and 1F). The remaining normally appearing
embryos had either the genotype Mterf4+/ (n = 17) orMterf4+/+
(n = 13). Loss of MTERF4 thus leads to a severely mutant pheno-
type at E8.5, similar to the phenotype seen in knockout embryos
lacking other genes that are essential for mtDNA expression,
e.g., TFAM (Larsson et al., 1998), TFB1M (Metodiev et al.,
2009), or MTERF3 (Park et al., 2007).
Loss of MTERF4 in Heart Causes Mitochondrial
Cardiomyopathy
We disrupted Mterf4 in heart (Figure 2) by breeding Mterf4loxP/+
mice with transgenic mice expressing cre-recombinase from
the muscle creatinine kinase promoter (Ckmm-cre), according
to previously described breeding protocols (Metodiev et al.,
2009; Park et al., 2007; Wang et al., 1999). The tissue-specific
Mterf4 knockouts (genotype Mterf4loxP/loxP, +/Ckmm-cre) mani-
fested a gradual increase of relative and absolute heart size with
increasing age (Figures 2A and S2A). Themaximal life span of the
Mterf4 knockouts was shortened to 21 weeks (data not shown),
and there was a decrease of body weight from age 15 weeks
(Figure S2B). We quantified MTERF4 mRNA levels by relative
real-time PCR and found >85% reduction in Mterf4 knockout
hearts at 5 and 20 weeks of age (Figure 2B). The low remaining
MTERF4 transcript levels may originate from other cell types in
the heart that are unaffected by the cardiomyocyte-specific
knockout. Ultrastructural analysis of the myocardium showed
a gradual accumulation of mitochondria with abnormal
morphology from 5 weeks of age and onward (Figures 2C and
2D), consistent with severe mitochondrial cardiomyopathy.
Further support for this conclusion was obtained by blue-native
polyacrylamide gel electrophoresis (BN-PAGE) analysis of
steady-state levels of respiratory chain complexes in Mterf4
knockout hearts (Figure 2E). Levels of assembled complexes
containing mtDNA-encoded subunits, i.e., complex I, III, IV,
and V, were decreased from 5 weeks of age and onward in
comparison with the exclusively nucleus-encoded complex II
(Figure 2E). BN-PAGE analyses of Mterf4 knockout hearts at
20 weeks of age revealed the presence of an a subunit-contain-
ing subcomplex of ATP-synthase (Figure 2E). We have previ-
ously observed a similar subcomplex in Mterf3 (Park et al.,
2007) and Tfb1m (Metodiev et al., 2009) knockout hearts, and
it likely represents the F1 part of the ATP synthase. Western
blot analyses were consistent with BN-PAGE results and
showed reduced levels of all mtDNA-encoded and some of the
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Figure 1. Conditional Disruption of the Mterf4 Gene and Analysis of Homozygous Knockout Embryos
(A) Targeting strategy for the conditional disruption of theMterf4 gene. A probe hybridizing a region downstream the 30 end of the targeting vector (Probe A) was
used for embryonic stem cell (ESC) clone screening by Southern blot analysis. A second probe hybridizing to exon 4 was used for analysis of the knockout allele
transmitted through the germline (Probe B). Probes used in Southern blot analysis are indicated as thick lines.
(B) Southern blot analysis of SpeI-digested DNA from control (C) and targeted (T) ESC clones revealed an additional band of 9.4 kb in the targeted ESC clones
(genotype Mterf4+/neo-loxP).
(C) Southern blot analysis of ApaLI-digested DNA from kidney of wild-type (Mterf4+/+) and Mterf4 heterozygous knockout (genotype Mterf4+/) mice.
Cre recombination generated a knockout fragment of 6.9 kb in the Mterf4+/ mice.
(D) Morphologic comparison of an Mterf4 knockout (/) and a heterozygous knockout control (+/) embryo at E8.5.
(E) Strategy for PCR genotyping of embryos. The used primer pairs are indicated by letters, and the expected PCR amplification products are 233 bp (primer pair
A), 595 bp (primer pair B), and 2058 bp (primer pair C). Red arrows show location of loxP sequences in the targeted loci.
(F) PCR analysis ofMterf4 genotype in E8.5 embryos. Analysis ofMterf4 knockout embryos (/) shows lack of amplification with primer pairs A and B, whereas
primer pair C generates a shorter band of 640 bp. See also Figure S1.
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Figure 2. Lack of MTERF4 in Heart Causes Mitochondrial Cardiomyopathy
(A) Heart to body weight ratio of control (L/L; white squares) and Mterf4 heart knockout (L/L, cre; black squares) mice at different ages. The number of
analyzed animals was as follows: 5 weeks (L/L, n = 15; L/L, cre, n = 6), 10 weeks (L/L, n = 5; L/L, cre, n = 9), 15 weeks (L/L, n = 7; L/L, cre, n = 7), and 20 weeks
(L/L, n = 23; L/L, cre, n = 20). Error bars indicate SEM; ***p < 0.001; **p < 0.01; *p < 0.05, Student’s t test.
(B) Real-time PCR quantification of relative MTERF4 mRNA levels in Mterf4 knockout (L/L, cre; black bars) and control (L/L; white bars) mouse hearts at 5 and
20 weeks of age. Pairs of animals used at 5 weeks, n = 4; 20 weeks, n = 5. Error bars indicate SEM; ***p < 0.001, Student’s t test.
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MTERF4-NSUN4 Regulates Mitochondrial Translationnuclear-encoded respiratory chain subunits analyzed (Figure 2F).
Measurement of respiratory chain function showed aprogressive
reduction in the activities of complex I, I+III, and IV, whereas the
complex II activity was reduced only in end-stage knockout
hearts (Figure 2G). The citrate synthase activity was elevated in
the Mterf4 knockout hearts (Figure S3A), in agreement with the
increase in mitochondrial biogenesis as observed by electron
microscopy (Figures 2C and 2D). Themitochondrial ATP produc-
tion rate (MAPR) showed a progressive and severe reduction in
Mterf4 knockout hearts (Figure S3B) and was thus consistent
with the observed respiratory chain deficiency (Figure 2G).
Loss of MTERF4 Causes a Massive Increase
of mtDNA Transcript Levels
The induction of severe respiratory chain deficiency in Mterf4
knockout hearts led us to investigate mtDNA levels and expres-
sion. We found increased levels of mtDNA by Southern blot
analysis (Figure S3C) and real-time PCR analyses (Figure S3D)
of end-stage Mterf4 knockout hearts. Furthermore, the total
cell extract levels of TFAM protein were increased (not shown),
but the ratio of TFAM to the outer mitochondrial membrane
protein VDAC was normal in end-stage Mterf4 knockout hearts
(Figures S3E and S3F). The increase of TFAMwas thus in propor-
tion to the amount of mitochondria and is therefore likely part
of a mitochondrial biogenesis response induced by defective
respiratory chain function.
Next, we performed northern blot analyses and found a
substantial increase in the steady-state levels of all mtDNA-
encoded mRNAs and of the 12S and 16S rRNAs in Mterf4
knockout hearts (Figures 3A–3C). This increase was in most
cases significant already at age 5 weeks, and it was very sub-
stantial in end-stage Mterf4 knockout hearts reaching 300%–
400% of normal levels for 12S rRNA and ND1 (Figure 3C). In
addition, we observed increased steady-state levels of
precursor transcripts containing ND1-16S (RNA19) and ND5-
Cytb sequences. We also assessed steady-state levels of tRNAs
(Figures 3A, 3D, and 3E) and found that tRNAs transcribed from
LSP were increased if they were encoded by promoter-proximal
genes (tRNAE and tRNAS1) and unchanged (tRNAQ, tRNAA,
tRNAN, and tRNAY) or decreased (tRNAC; 57% of control levels
remaining) if they were encoded by promoter-distal genes (Fig-
ure 3E). The tRNAs transcribed from HSP were all increased
regardless of the position of their genes in relation to the HSP
promoter (Figure 3A).
We further investigated the cause of the increased transcript
steady-state levels by in organello transcription assays and
found a massive increase of de novo transcription in Mterf4(C) Quantification of relative mitochondrial mass obtained by electron microscop
of animals used at 5 weeks, n = 4; 10 weeks, n = 5; 20 weeks, n = 5). Error bars
(D) Representative electron micrographs of control (L/L) and end-stage Mterf4 k
(E) BN-PAGE analysis of levels of assembled respiratory chain complexes in
Immunodetections of nuclear-encoded subunits were performed for complex I (N
complex V (ATP5A1).
(F) Steady-state levels of respiratory chain subunits in mitochondrial extracts fr
mtDNA-encoded (COXI and ATP8) and nuclear-encoded subunits (NDUFA9, SD
(G) Relative enzymatic activities of respiratory chain complexes in the heart of cont
The analyzed enzyme activities are: NADH cytochrome c reductase (Complex
(Complex II), succinate cytochrome c reductase (Complex II/III), and cytochrom
synthase (CS) activity. Pairs of animals used, n = 3. Error bars indicate SEM. **p
Cknockout hearts at 10 and 20 weeks of age (Figure 4A). The
increase of de novo transcription correlated with increased
levels of TFB2M protein, which activates transcription (Falken-
berg et al., 2002; Metodiev et al., 2009), from week 5 and
decreased levels of MTERF3 protein, which represses mtDNA
transcription (Park et al., 2007), from week 15 (Figure 4B). These
findings suggest that the increased steady-state levels of
mtDNA-encoded transcripts (Figure 3) are explained by activa-
tion of de novo transcription, probably as a component of a
mitochondrial biogenesis response.
Impaired Translation and Defective Ribosomal
Assembly in the Absence of MTERF4
The observed respiratory chain deficiency (Figures 2C–2G, S3A,
and S3B) motivated us to investigate the de novo protein
synthesis in isolated mitochondria. We performed assays on
mitochondria isolated from 20-week-oldMterf4 knockout hearts
and found a severe decrease of in organello translation (Fig-
ure 4C). This puzzling combination of massively increased
mtDNA transcription (Figure 3 and 4A) and impaired translation
(Figure 4C) prompted us to further analyze the mitochondrial
ribosomes.
The MRPS15 and MRPL13 proteins of the small (28S) and the
large (39S) ribosomal subunit, respectively, were increased on
western blot analyses of mitochondria from Mterf4 knockout
hearts (Figure 4D). These results are in agreement with the
observed increase in steady-state levels of 12S and 16S rRNA
(Figure 3) and suggest increased biogenesis of mitochondrial
ribosomes. In line with this idea, we also observed increased
levels of the TFB1M protein (Figure 4B), which is necessary for
methylation of 12S rRNA, which in turn regulates the stability of
the 28S ribosomal subunit (Metodiev et al., 2009).We proceeded
to isolate and fractionate mitochondrial ribosomes from Mterf4
knockout hearts and found dramatically increased levels of the
28S and 39S subunits (Figure 4E), consistent with the increase
of ribosomal protein levels (Figure 4D). However, there was no
corresponding increase in the levels of the fully assembled
(55S) ribosome (Figure 4E). These findings indicate that the
28S and 39S ribosomal subunits are stable, but that either they
do not interact to form the 55S ribosome or the stability of the
fully assembled ribosome is compromised in the absence of
MTERF4.
MTERF4 Binds 16S and 12S rRNA and Interacts
with NSUN4
The defective translation in the absence of MTERF4 encouraged
us to perform RNA immunoprecipitation (RIP) experiments toy analysis of control (white bars) andMterf4 knockout (black bars) hearts (pairs
indicate SEM; ***p < 0.001; **p < 0.01; *p < 0.05, Student’s t test.
nockout (L/L, cre) hearts. Scale bar 1 mm.
control (L/L) and Mterf4 knockout (L/L, cre) hearts at age 5 and 20 weeks.
DUFA9), complex II (SDHA), complex III (UQCRC2), complex IV (COXIV), and
om control (L/L) and Mterf4 knockout (L/L, cre) hearts at different ages. Both
HA, UQCRC2, and ATP5A1) were analyzed by western blot.
rol (white bars) andMterf4 heart knockout (black bars) animals at different ages.
I/III), NADH coenzyme Q reductase (Complex I), succinate dehydrogenase
e c oxidase (Complex IV). All enzyme activities are normalized to the citrate
% 0.01; ***p < 0.001; Student’s t test. See also Figure S2.
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Figure 3. Steady-State Levels of Mitochondrial rRNAs, mRNAs, and tRNAs in Mterf4 Knockout Hearts
(A) Linear map of mouse mtDNA indicating the relative position of the light- (LSP) and heavy-strand (HSP) promoters. The rRNA and protein coding genes as
well as some transcripts corresponding to mRNA precursors are indicated by boxes. The tRNA genes are indicated with dots and single-letter amino acid
abbreviations.
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Figure 4. Transcription and Translation in Mterf4 Knockout Heart Mitochondria
(A) In organello transcription of control (L/L) and Mterf4 knockout (L/L, cre) heart mitochondria from 10- or 20-week-old animals.
(B) Western blot analysis of MTERF3, TFB1M, and TFB2M steady-state protein levels in mitochondrial extracts from control (L/L) andMterf4 knockout (L/L, cre)
hearts at different ages. VDAC was used as a loading control.
(C) De novo mitochondrial translation in control (L/L) and Mterf4 knockout (L/L, cre) heart mitochondria from 20-week-old animals (left panel). Coomassie blue
staining of the polyacrylamide gels was used to verify even loading of all lanes (right panel). The position of the COXI, COXII, and ATP8 proteins is indicated.
(D) Steady-state levels of the MRPL13 protein of the large (39S) ribosomal subunit and the MRPS15 protein of the small (28S) ribosomal subunit analyzed by
western blots of mitochondria from control (L/L) and Mterf4 knockout (L/L, cre) hearts of mice at different ages. VDAC was used as a loading control.
(E) Sedimentation analysis of the small (28S) ribosomal subunit, the large (39S) ribosomal subunit, and the assembled (55S) ribosome in control (L/L) andMterf4
knockout (L/L, cre) heart mitochondria from 20-week-old mice, by centrifugation through linear 10%–30% sucrose density gradient. The different fractions
(numbered) were analyzed by SDS-PAGE and subsequent western blotting. The migration of the ribosomal subunits and the fully assembled ribosome were
determined by immunodetection of comigrating MRPS15 and MRPL13.
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MTERF4-NSUN4 Regulates Mitochondrial Translationinvestigate whetherMTERF4 binds specificmitochondrial RNAs.
The RIP analyses demonstrated that hMTERF4-Flag was cross-
linked preferentially to 16S rRNA, but also to 12S rRNA and 7S
RNA (Figure 5A). The crosslinking to 7S RNA suggests that
MTERF4 is not only present at the ribosome but also in imme-
diate proximity to the LSP, consistent with the suggestion that
MTERF4 perhaps also has a role in modifying mitochondrial
transcription.
Based on these interactions between MTERF4 and rRNA, we
proceeded to investigate whether MTERF4 interacts with other
proteins in rRNA metabolism. We isolated mitochondria from
stably transfected HeLa cells and performed a large-scale im-(B) Northern blot analyses of mitochondrial transcripts in control (L/L) and Mterf4
used as a loading control. Number of animal pairs used: n = 6.
(C) Quantification of steady-state levels of mitochondrial transcripts in control (
densitometric analysis of northern blots. Nuclear-encoded 18S rRNA was used a
n = 6; 10 weeks, n = 5; 15 weeks, n = 5; 20 weeks, n = 6. Error bars indicate SE
(D) Northern blot analyses of mitochondrial tRNAs in control (L/L) andMterf4 knoc
a loading control. Number of animal pairs used: n = 4.
(E) Quantification of steady-state levels of tRNAs in control (white bars) andMterf4
northern blots. Nuclear-encoded 18S rRNA was used as a loading control. Numb
bars indicate SEM; ***p% 0.001; **p% 0.01; *p% 0.05, Student’s t test. See al
Cmunopurification of the hMTERF4-Flag protein in search for
putative interacting partners of the protein. When the immuno-
purified fraction was analyzed by SDS-PAGE and Coomassie
blue staining, a lower-molecular-mass protein was observed in
addition to MTERF4 (Figure 5B). MALDI-TOF analysis identified
this protein as NSUN4 (NOL1/NOP2/Sun domain family,
member 4; NCBI entry: NP950245.2). Furthermore, we used
NSUN4 antibodies for immunoprecipitation of mitochondrial
extracts from cells expressing hMTERF4-Flag and could immu-
noprecipitate MTERF4 (Figure 5C). The complex can thus be
immunoprecipitated by targeting either of the two components.
We found a high probability of mitochondrial localization ofknockout (L/L, cre) hearts at age 20 weeks. Nuclear-encoded 18S rRNA was
white bars) and Mterf4 knockout (black bars) hearts. Data were obtained by
s a loading control. Number of L/L and L/L, cre animals analyzed at 5 weeks,
M; ***p% 0.001; **p% 0.01; *p% 0.05, Student’s t test.
kout (L/L, cre) hearts at age 20 weeks. Nuclear-encoded 18S rRNAwas used as
knockout (black bars) hearts. Data were obtained by densitometric analysis of
er of L/L and L/L, cre animals analyzed at 5 weeks, n = 6; 20 weeks, n = 4. Error
so Figure S3.
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Figure 5. MTERF4 Binds rRNA and Forms a Complex with NSUN4
(A) RNA immunoprecipitation (RIP) experiments were performed in hMTERF4-Flag-expressing HeLa cells, and transcripts interacting with MTERF4 were
determined by real-time RT-PCR. RNA interactions were measured after in vivo formaldehyde crosslinking of HeLa cells prior to isolation of mitochondria.
TaqMan Gene Expression Assays (Applied Biosystems) were used to identify the indicated mitochondrial transcripts. The graph shows relative enrichment of
each of the analyzed transcripts in HeLa cells expressing the hMTERF4-Flag protein in comparison with control HeLa cells. Error bars indicate SEM.
(B) Coomassie-stained SDS-PAGE depicting the hMTERF4-Flag-hNSUN4 protein complex obtained after immunopurification of hMTERF4-Flag from stably
transfected HeLa cells. Protein identity was confirmed by MALDI-TOF.
(C) Immunoprecipitation with hNSUN4 antibodies in mitochondria from HeLa cells expressing hMTERF4-Flag. Western blot analysis of input, unbound, and
eluate fractions shows that the hNSUN4 antibodies specifically immunoprecipitate MTERF4 (detected with an anti-Flag antibody). VDAC immunodetection was
used to verify the immunoprecipitation specificity.
(D) Size-exclusion chromatography of protein extracts from insect cells expressing recombinant hNSUN4 (upper panel), hMTERF4 (middle panel), or both
hNSUN4 and hMTERF4 (lower panel). Fractions are indicated by numbers, and elution points for molecular mass standards are indicated by arrows. The
indicated standards were used for calculating a calibration curve (R2 = 0.9978) to determine the apparent molecular masses of the expressed recombinant
proteins. See also Figure S4.
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MTERF4-NSUN4 Regulates Mitochondrial TranslationNSUN4 by using the Mitoprot (58.9%) and TargetP (77.1%) soft-
wares. The subcellular localization of NSUN4 fused at its C
terminus to enhanced yellow fluorescent protein (EYFP) was
determined by transfection of HeLa cells and subsequent live-
cell imaging with MitoTracker Deep Red FM counterstaining.
The NSUN4-EYFP colocalizes with the mitochondrial network
with a colocalization rate of 99.1% ± 0.4% (N = 6 cells) (Fig-
ure S4A). We performed in vitro import experiments and found
that NSUN4 contains a mitochondrial leader peptide that is
cleaved after import (Figure S4B). We proceeded to determine
the amino-terminal sequence of hNSUN4 by using the protein
found in complex with hMTERF4-Flag (Figure 5B). Edman
degradation showed that the N-terminal sequence of the mito-
chondrial isoform of hNSUN4 starts at amino acid residue 26
(Figure S4C).
We used baculovirus vectors to express the mitochondrial
isoforms of hMTERF4 and hNSUN4 in insect cells. Purified534 Cell Metabolism 13, 527–539, May 4, 2011 ª2011 Elsevier Inc.hNSUN4 had an apparent molecular weight of 33 kDa on size-
exclusion chromatography (SEC), which is in good agreement
with the predicted weight of 40 kDa, whereas purified hMTERF4
had an apparent molecular weight of 78 kDa, which was signifi-
cantly larger than the predicted weight of 35 kDa, possibly cor-
responding to a dimeric conformation (Figure 5D). However,
sometimes there is a poor relationship between the hydrody-
namic volume of a protein and its molecular weight, and the
molecular weight is therefore not always accurately determined
by SEC (Gangelhoff et al., 2009). We next investigated if
hMTERF4 could form a complex with hNSUN4 upon coexpres-
sion in insect cells. Our analysis revealed that the two proteins
comigrated on SEC and formed a protein complex with a pre-
dicted molecular weight of 112 kDa, clearly distinct from that
observed with any of the two proteins in isolation (Figure 5D).
We further analyzed the stoichiometry of the purified
hMTERF4/hNSUN4 complex in solution by using a quantitative
Figure 6. Homology Modeling of Human
NSUN4
(A) Superimposition of H.s. NSUN4 (gray) model
with the multisite 16S rRNA m5C methyltransfer-
ase RsmF (orange) from Thermus thermophilus
that methylates C1400, C1404, and C1407
(Demirci et al., 2010). The C-terminal substrate
recognition domain of RsmF is not shown.
(B) Superimposition of H.s. NSUN4 model (gray)
with the 16S rRNA m5C methyltransferase RsmF
(pink) from Escherichia coli that methylates C1407
(Hallberg et al., 2006). The C-terminal substrate
recognition domain of RsmF is not shown.
(C) Superimposition of H.s. NSUN4 model (gray)
with the 16S rRNA m5C methyltransferase RsmB
(blue) from Escherichia coli that methylates C967.
(D) Active-site close-up of H.s. NSUN4 with resi-
dues essential for m5C activity shown in stick
mode. See also Figure S5.
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MTERF4-NSUN4 Regulates Mitochondrial Translationmass spectrometry approach (Silva et al., 2006). We obtained
a relative ratio of MTERF4:NSUN4 of 100:88, suggesting that
the complex is a heterodimer.
NSUN4 Is an RNA m5C Methyltransferase
NSUN4 contains all the necessary sequence signature motifs
characterizing the RNA m5C methyltransferase family (Fig-
ure S5). To verify that NSUN4 also retains a functional active
site configuration, we performed homology modeling of
NSUN4 using available, experimentally determined, RNA m5C
methyltransferase structures. The modeling shows that NSUN4
constitutes a single but typical RNA m5C methyltransferase
domain without extraneous RNA substrate recognition domains
or surfaces (Figure 6). Furthermore, active site residues, which
are necessary for SAM cosubstrate recognition andmethyltrans-
ferase activity, are structurally conserved in 3D space in NSUN4
(Figure 6D).
MTERF4 Targets NSUN4 to the Large Subunit
of the Ribosome
We next investigated whether the MTERF4-NSUN4 complex
directly interacts with the mitochondrial ribosome. We carried
out a sedimentation gradient analysis of mitochondrial ribo-
somes isolated from stably transfected HeLa cells expressing
hMTERF4-Flag. We used antibodies against hMRPS11 and
MRPL13 to visualize the small ribosomal subunit (28S), the largeCell Metabolism 13, 527–ribosomal subunit (39S), and the assem-
bled ribosome (55S) (Figure 7A). The
hMTERF4-hNSUN4 complex comigrates
with the large ribosomal subunit (Fig-
ure 7A). This result is in agreement with
the finding that MTERF4 mainly binds
16S rRNA (Figure 5A), and it is well in
line with the suggestion that the
MTERF4-NSUN4 complex is targeted to
the large ribosomal subunit to modify
rRNA.
Bioinformatics analyses (Figure S5)
and structural modeling (Figure 6) ofNSUN4 predict that it lacks an RNA recognition domain, and it
is therefore in need of a binding partner protein for targeting
the ribosome. We investigated whether MTERF4 can perform
this targeting role in mammalian mitochondria by using RNAi to
decrease the expression of MTERF4 in HeLa cells. We found
that knockdown of MTERF4 had no major effect on the absolute
levels of NSUN4 (Figure 7B), but the targeting of NSUN4 to the
large ribosomal subunit was strongly decreased (Figures 7C
and 7D). We also investigated the in vivo situation in Mterf4
knockout hearts and found that the absolute levels of NSUN4
were slightly increased in the absence of MTERF4 (Figure 7E),
likely as a consequence of the observed induction of mitochon-
drial biogenesis. However, NSUN4 was not targeted to the large
subunit of the ribosome in the absence of MTERF4 (Figure 7F).
We thus conclude MTERF4 is necessary for targeting the
NSUN4 methyltransferase to the ribosome.
DISCUSSION
We demonstrate here that MTERF4, a member of the MTERF
family of transcription factors, has an unexpected role in regula-
tion of ribosomal biogenesis and mitochondrial translation.
Mitochondrial translation is severely impaired in Mterf4 heart
knockout mitochondria because the two ribosomal subunits
are not assembled to a functional mitochondrial ribosome
despite being present at increased levels. The role for MTERF4539, May 4, 2011 ª2011 Elsevier Inc. 535
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Figure 7. MTERF4 Is Necessary for Targeting NSUN4 to the Large Ribosomal Subunit
(A) Sedimentation analysis of the small (28S) ribosomal subunit, the large (39S) ribosomal subunit, and the assembled (55S) ribosome in HeLa cells expressing
hMTERF4-Flag by centrifugation through linear 10%–30% sucrose density gradient. Themigration of the 28S and 39S subunits and the assembled ribosomewas
determined by immunodetection of hMRPS11 and hMRPL13. Both hNSUN4 and hMTERF4-Flag partially comigrate with the 39S subunit. The different fractions
are numbered.
(B) Western blot analysis of MTERF4 and NSUN4 protein levels in HeLa cells treated with control siRNA and siRNA specific for MTERF4. VDAC was used as
loading control.
(C) Sedimentation analysis of the large (39S) ribosomal subunit and the assembled (55S) ribosome in control HeLa cells (control) and HeLa cells transfected with
siRNAs (MTERF4 KD) by centrifugation through linear 10%–30% sucrose density gradient. The proportion of the total NSUN4 protein levels that comigrate with
the 39S ribosomal subunit is decreased in MTERF4 KD cells.
(D) Quantification of the relative amount of NSUN4 that comigrates with the 39S ribosomal subunit in control and MTERF4 KD HeLa cells. Quantification was
performed using infrared densitometry (Odyssey, Li-Cor Biosciences, GmbH).
(E) Western blot analysis of NSUN4 protein levels in control (L/L) and Mterf4 knockout (L/L, cre) hearts at age 20 weeks. VDAC was used as loading control.
(F) Sedimentation analysis of the large (39S) ribosomal subunit and the assembled (55S) ribosome in control (L/L) and Mterf4 knockout (L/L, cre) heart mito-
chondria from 20-week-old mice by centrifugation through a linear 10%–30% sucrose density gradient. The comigration between NSUN4 and the 39S ribosomal
subunit is almost entirely abolished inMterf4 knockout hearts. The very small amount of NSUN4 still comigrating with the 39S ribosomal subunit may be derived
from other cell types in the heart unaffected by the knockout.
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MTERF4-NSUN4 Regulates Mitochondrial Translationin regulation of ribosomal biogenesis is explained by the finding
that it forms a stoichiometric complex with NSUN4, a mitochon-
drial protein. NSUN4 belongs to a family of m5C RNA methyl-
transferases present in all kingdoms of life (Reid et al., 1999).
In prokaryotes, the RNA m5C methyltransferase domains are
typically fused either N-terminally or C-terminally to RNA recog-
nition domains, such as a PUA domain in the case of YebU from
E. coli (Reid et al., 1999; Hallberg et al., 2006). The NSUN4
protein lacks this targeting domain and instead forms a protein
complex with MTERF4, which is essential for recruiting NSUN4
to the large mitochondrial ribosomal subunit, thanks to its
ability to bind 16S rRNA. This dependency on protein complex
formation for targeting of the enzyme activity to its substrate is
reminiscent of the situation in unicellular eukaryotes, where
RNA recognition and m5C methylation often are dependent on
different proteins interacting in a macromolecular complex.
One such example is the yeast protein complex, consisting of536 Cell Metabolism 13, 527–539, May 4, 2011 ª2011 Elsevier Inc.Nop8p, a nuclear m5C RNA methyltransferase homologous to
NSUN4, and Nip7p, a PUA domain-containing protein required
for substrate recognition. The Nop8p/Nip7p complex is critical
for biogenesis of the 27S ribosomal subunit and assembly of
the 60S cytoplasmic ribosome in yeast (Zanchin and Goldfarb,
1999; Zanchin et al., 1997).
Interestingly, an NSUN4 homolog, the E. coli protein YebU,
responsible for methylation of a cytosine at position 1407 of
the rRNA of the small bacterial ribosomal subunit (Andersen
and Douthwaite, 2006), methylates only the rRNA if it is present
in the assembled small ribosomal subunit and cannot methylate
the free rRNA (Andersen and Douthwaite, 2006; Hallberg et al.,
2006). Loss of YebU causes a rather mild phenotype with slow
growth and reduced fitness in E. coli. In analogy, we have previ-
ously shown that TFB1M is essential for dimethylation of two
adenines in a very highly conserved stem-loop structure at the
30 end of 12S rRNA (Metodiev et al., 2009). Disruption of the
Cell Metabolism
MTERF4-NSUN4 Regulates Mitochondrial TranslationTfb1m gene in the heart leads to impaired assembly of the small
subunit of the mitochondrial ribosome and abolished mitochon-
drial translation (Metodiev et al., 2009). Interestingly, disruption
of KsgA, the E. coli homolog of Tfb1m, also led to loss of dime-
thylation of the conserved adenines, but the resulting bacterial
phenotype is rather mild. Hence, loss of MTERF4-NSUN4
complex formation and TFB1M expression causes grave pheno-
types in mammalian mitochondrial ribosomes, whereas inactiva-
tion of the bacterial homologs to NSUN4 and TFB1M seems to
have rather mild consequences.
All of the previously studied MTERFs have been implicated in
regulation of transcription initiation (Martin et al., 2005; Park
et al., 2007; Wenz et al., 2009). There is strong activation of de
novo transcription of mtDNA with a massive global increase of
steady-state levels of mRNAs, reaching in some cases more
than 300% of control levels, inMterf4 knockout heart mitochon-
dria. This effect is likely due to an activation of mitochondrial
biogenesis in response to the severely defective translation,
involving increased expression of the transcriptional activator
TFB2M and downregulation of the transcription repressor
MTERF3. A similar strong activation of transcription has previ-
ously been observed in mouse hearts with severely impaired
translation due to knockout of Tfb1m (Metodiev et al., 2009).
The observation that this massive activation of transcription
can occur in the absence of MTERF4 shows that this factor is
not essential for inducing this long-term transcriptional
response. It is possible that alsoMTERF4 interacts with the other
MTERFs tomodulatemtDNA transcription, but amolecular basis
for such an interaction remains to be determined.
In conclusion, we demonstrate here that MTERF4, which
belongs to a family of transcription regulators in mammalian
mitochondria, forms a stable stoichiometric complex with
NSUN4, a mitochondrial RNA m5C methyltransferase. MTERF4
is necessary for targeting NSUN4 to the large ribosomal subunit,
and loss of MTERF4 leads to increased steady-state levels of
both ribosomal subunits, but no assembly into functional ribo-
somes. MTERF4 belongs to a family of transcription factors,
and the prokaryote-like organization of mitochondria with no
compartmentalization between transcription and translation
may enable direct crosstalk between both processes. Our data
demonstrate that MTERF4 has a critical role in translation, and
future studies will be necessary to determine whether it also
has a role in transcription and may even link the two processes.EXPERIMENTAL PROCEDURES
Generation of MTERF4 Conditional Knockout Mice
We engineered a targeting vector where exon 2 of theMterf4 gene was flanked
by two loxP sites (Figure 1A). A loxP site was inserted in the intron located 30 to
exon 2, whereas an Frt-PGK-neo-Frt cassette (Frt-site-flanked neomycin gene
expressed from the phosphoglycerate kinase promoter) with an adjacent
second loxP site was inserted in the intron located 50 to exon 2. To construct
the targeting vector, genomic clones containing the mouse Mterf4 gene were
isolated from a 129Sv RCPI-22M BAC library (Invitrogen). A NheI-NaeI frag-
ment of 12 kb with the Mterf4 gene was cloned by ET-recombination into
pBluescript II SK+ (pBS, Stratagene) to generate the pBST4 plasmid. The
pDELBOY-3X plasmid contains an Frt-PGK-neo-Frt cassette with a single
adjacent loxP sequence. We introduced two ApaLI sites into XhoI and KpnI
sites of pDELBOY. This modification allowed excision of the Frt-PGK-neo-
Frt cassette and the adjacent loxP sequence by ApaLI digestion of pDEL-
BOY-3X. The ApaLI fragment excised from the modified pDELBOY-3XCplasmid was then ligated into ApaLI-digested pBST4 to create pBST4neo.
Similarly, an oligonucleotide containing BglII sites was introduced in the modi-
fied pDELBOY-3X plasmid at the EcoRI and KpnI sites to allow later excision of
a loxP sequence by BglII digestion. The BglII fragment from the modified
pDELBOY-3X was ligated with BglII-digested pBST4-neo to generate the final
targeting vector construct, denoted pBST4KO. The targeting vector was line-
arized with NotI and electroporated into 129R1 embryonic stem cells (ESCs).
ESC clones that had undergone homologous recombination after transfection
with pBST4KO were identified by Southern blot analysis. Total genomic ESC
DNA was digested with the SpeI restriction enzyme and analyzed by Southern
blotting with an a-32P-dCTP-labeled probe recognizing in an area 30 to the
targeted region (Figure 1B).
Positive clones were injected into blastocysts, and chimeric mice were
obtained. Germline transmission of the targeted allele was achieved by mating
chimeric mice to C57BL/6 animals. The Frt-flanked PGK-neo cassette was
excised by matingMterf4+/neo-loxP mice (Figure 1A) to transgenic mice ubiqui-
tously expressing Flp-recombinase, thus generating Mterf4+/loxP mice
(Figure 1A). Mterf4+/loxP mice were mated with transgenic mice ubiquitously
expressing cre-recombinase (b-actin-cre) to generate heterozygous knockout
mice (Mterf4+/) (Figure 1A).
Tissue-Specific Disruption of Mterf4
Heart- and skeletal muscle-specific knockout mice were generated as
described previously (Metodiev et al., 2009; Park et al., 2007; Wang et al.,
1999). Essentially, Mterf4loxP/loxP mice were mated to transgenic mice ex-
pressing cre-recombinase under the control of the muscle creatinine kinase
promoter (Ckmm-cre). From this mating, double heterozygous mice
(Mterf4loxP/+, +/Ckmm-cre) were generated and crossed to Mterf4loxP/loxP
mice to obtain tissue-specific knockouts (Mterf4loxP/loxP, +/Ckmm-cre). All
crosses yielded offspring at expected Mendelian proportions.
Immunoprecipitation of RNA-Protein Complexes
We combined and adapted previously described methods (Lejeune and
Maquat, 2004; Niranjanakumari et al., 2002; Peritz et al., 2006) to analyze
RNA-protein complexes. We seeded 10 3 150 mm plates with hMTERF4-
Flag and control HeLa cells and treated cells with 1 mg/ml doxycycline when
they had reached 50% confluency. After 48 hr, cells were washed with
PBS and crosslinked by gently rocking the plates for 10 min at room temper-
ature in a 0.5% formaldehyde-PBS solution. The crosslinking reaction was
quenched by adding glycine (pH 7.0) to a final concentration of 0.25 M and
gently rocking the plates for 5 min. Crosslinked and noncrosslinked plates
were washed twice with ice-cold PBS, and cells were scraped from the plates
in 2 ml mitochondrial isolation buffer B (see Supplemental Experimental
Procedures) supplemented with 13 complete EDTA-free protease inhibitor
cocktail (Roche). Cells were homogenized by passage ten times through
a 22G needle. Mitochondria were isolated by differential centrifugation as
follows: The cell lysate was centrifuged for 10 min at 1500 g at 4C. The super-
natant was collected and centrifuged at 10,000 g for 10 min at 4C. The
mitochondrial pellet was suspended in 1 ml mitochondrial isolation buffer B
supplemented with 13 complete EDTA-free protease inhibitor cocktail
(Roche), and a second centrifugation at 10,000 g for 10 min at 4C was per-
formed. The final mitochondrial pellet was fast-frozen in liquid nitrogen and
suspended in a low-salt NET-2 buffer (50 mM Tris-HCl [pH 7.4], 150 mM
NaCl, 0.05%Nonidet P-40, 13 complete EDTA-free protease inhibitor cocktail
[Roche]) supplemented with 100 U of RNasin Plus (Promega). The mitochon-
drial fraction was then lysed by passing through a 30G needle five times and
centrifuged at 10,000 g for 10 min at 4C. The protein concentration of the
mitochondrial lysates was measured using a Bradford-based assay (Sigma).
For immunoprecipitation, 200 mg mitochondrial protein was used. Lysates
were precleared with mouse IgG agarose beads (Sigma) by rotation for 1 hr
at 4C and then incubated in rotation for 2 hr at 4C with Anti-Flag M2 Affinity
Gel (Sigma), which had previously been incubated with 100 mg yeast tRNA for
1 hr to block unspecific binding of RNA to the agarose beads. Following incu-
bation, beads were initially washed by rotation for 23 10min at 4C in low-salt
NET-2 buffer. The beads were then washed for 2 3 5 min in high-salt NET-2
buffer (50 mM Tris-HCl [pH 7.4], 300 mM NaCl, 0.05% Nonidet P-40, 13
complete EDTA-free protease inhibitor cocktail [Roche]), and a final wash
was performed for 4 3 10 min in low-salt NET-2 buffer. The washed beadsell Metabolism 13, 527–539, May 4, 2011 ª2011 Elsevier Inc. 537
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MTERF4-NSUN4 Regulates Mitochondrial Translationwere resuspended in 120 ml reversion buffer (50 mM Tris-HCl [pH 6.8], 1%
SDS, 5 mM EDTA, 10 mM DTT), vortexed for 1 min, and then incubated for
45 min at 70C. After reversion of crosslinks, 20 ml of resuspended beads
were stored for later western blot analyses. RNA was isolated by mixing the
remaining 100 ml of suspended beads with 300 ml TRIzol, followed by addition
of 80 ml chloroform. After 10 min incubation at room temperature, the organic
and aqueous phases were separated by centrifugation at 12,000 g for 10 min
at 4C. The aqueous phase was collected and subjected to overnight isopro-
panol precipitation in the presence of 10 mg yeast tRNA (Ambion) as a carrier.
The RNA precipitate was collected by centrifugation at 12,000 g for 15 min at
4C, washed with 70% ethanol, air-dried, and resuspended in RNase-free
water. The samples were subjected to DNase I (Invitrogen) treatment and
reverse transcribed to cDNA by using the High-Capacity cDNA Archive kit
(ABI). Mitochondrial transcripts in the immunoprecipitate were identified and
quantified by real-time PCR. The following predesigned TaqManGene Expres-
sion Assays (Applied Biosystems) were used: MT-ND1 (Hs02596873_s1),
MT-ND6 (Hs02596879_g1), MT-CYB (Hs02596867_s1), MT-COI
(Hs02596864_g1), MT-ATP6 (Hs02596862_g1), MT-RNR1 (Hs02596859_g1),
MT-RNR2 (Hs02596860_s1), MT-7S (Hs02596861_s1), MT- L_Ala_to_Gln
(Hs02596868_g1), MT- L_Pro_to_Glu (Hs02596871_s1), and MT- L_Ser1_to_
Tyr (Hs02596872_g1). The background levels were defined as the RNA levels
immunoprecipitated with the anti-Flag M2 antibody in the HeLa control cells.
HeLa control cells and HeLa cells expressing hMTERF4-Flag were analyzed
in parallel for each experimental condition.
Gel Filtration Chromatography and Mass Spectrometry
Quantification
Mature mitochondrial isoforms of the hMTERF4 protein and the hMTERF4/
hNSUN4 protein complex were expressed in Spodoptera frugiperda (Sf9)
insect cells by using recombinant baculovirus constructs, as previously
described (Korhonen et al., 2003). For gel filtration chromatography, both
NSUN4 (lacking residues 1–25) andMTERF4 (lacking residues 1–47) were puri-
fied over Ni-NTA, Heparin, and MonoQ (GE Healthcare). The NSUN4-MTERF4
complex obtained after coexpression was purified only over Ni-NTA (GE
Healthcare). Proteins were dialyzed against gel filtration buffer (10% glycerol,
0.5 mM EDTA, 200 mM NaCl, 1 mM DTT, 20 mM Tris-HCl [pH 8.0]) at 4C for
4–12 hr. A total protein sample volumeof 200–500ml was analyzed bySuperose
12chromatography (GEHealthcare), keepingaconstant flow rateof 0.4ml/min.
Fractions of 200 ml were collected. In addition, 90 ml of a molecular mass stan-
dard (Bio-Rad) in gel filtration buffer was used as reference for these studies.
The stoichiometry of MTERF4/NSUN4 complex in solution was determined
by in-solution digestion with trypsin (Promega Trypsin Gold mass spec grade)
and analysis of the peptide mixture by nano-UPLC and Xevo-Q-Tof MSE
(Waters). NSUN4 and MTERF4 were identified with 21 (43% sequence
coverage) and 27 peptides (38% sequence coverage), respectively. For rela-
tive quantification it was assumed arbitrarily that 100 fmol absolute amount
of NSUN4 was loaded on the column. The Hi3 algorithm (Waters) calculated
the amount of MTERF4 to 88 fmol. This means NSUN4 and MTERF4 exist in
solution as a 1:1 mixture.
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